BACKGROUND : While the incidence of new-onset diabetes mellitus may be increasing in patients with schizophrenia treated with certain atypical antipsychotic agents , it remains unclear whether atypical agents are directly affecting glucose metabolism or simply increasing known risk factors for diabetes .
O O O O O O O B-DiseaseOrPhenotypicFeature I-DiseaseOrPhenotypicFeature O O O O B-OrganismTaxon O B-DiseaseOrPhenotypicFeature O O O O B-ChemicalEntity I-ChemicalEntity O O O O O O O O O O B-ChemicalEntity O O O O O O O O B-DiseaseOrPhenotypicFeature O